Study findings updated . AI-assisted evidence summary, not individual medical advice or a clinician endorsement.
Key findings
43 daysUntil extra mood-disorder risk after COVID matched that after other infections
Mood-disorder risk after COVID faded fast; psychosis risk lingered 2 years.
Among more than a million people diagnosed with COVID-19, compared with matched people who had other respiratory infections, the extra risk of a new mood disorder such as depression faded after 43 days, and of anxiety after 58 days. But psychotic disorders, dementia and 'brain fog' (trouble thinking clearly) were still being diagnosed more often after COVID at the end of 2 years.
The feared wave of lasting depression after infection looks short-lived when COVID is compared with other chest infections. The longer-lasting signal is for rarer brain-related diagnoses such as psychosis and dementia, which deserve close follow-up. This used health records, mostly from the USA, through April 2022, so it relies on recorded diagnoses and cannot prove cause; a VA study comparing with uninfected people did find more depression.
A records study from the TriNetX network of about 89 million patients, mostly in the USA, matching COVID-19 patients diagnosed January 2020 to April 2022 with patients who had other respiratory infections.
From the study: “Risks of the common psychiatric disorders returned to baseline after 1-2 months (mood disorders at 43 days, anxiety disorders at 58 days)”
43 days
Taquet M et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The lancet. Psychiatry. 2022.
From the study: “By contrast, risks of cognitive deficit (known as brain fog), dementia, psychotic disorders, and epilepsy or seizures were still increased at the end of the 2-year follow-up period.”
43 days
Taquet M et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The lancet. Psychiatry. 2022.
1.4× depression riskHazard ratio, new depressive disorders within a year of COVID vs uninfected veterans
Veterans were more often diagnosed with depression in the year after COVID.
US veterans who survived the first 30 days of COVID-19 were diagnosed with new depressive disorders at 1.39 times the rate of similar veterans with no sign of infection, which works out to 15.12 extra cases per 1000 people over a year. New anxiety, stress and substance use disorders were also more common, even among those never hospitalized.
The rise was not limited to severe cases: veterans who recovered at home also showed it. Spread across millions of infections, a modest per-person rise means many more people needing mental health care. The veterans were mostly older white men and this records study cannot prove cause; a larger study comparing COVID with other respiratory infections found the extra depression risk faded within months.
A US Department of Veterans Affairs health-records study that followed veterans who survived COVID-19 for about a year and compared them with millions of uninfected veterans.
From the study: “depressive disorders (1.39 (1.34 to 1.43); 15.12 (13.38 to 16.91) per 1000 people at one year)”
1.4× depression risk
Xie Y et al. Risks of mental health outcomes in people with covid-19: cohort study. BMJ (Clinical research ed.). 2022.
From the study: “The risks of examined outcomes were increased even among people who were not admitted to hospital”
1.4× depression risk
Xie Y et al. Risks of mental health outcomes in people with covid-19: cohort study. BMJ (Clinical research ed.). 2022.
2.7× odds of dyingOdds ratio for death within 45 days, schizophrenia vs no psychiatric diagnosis
Schizophrenia was linked to much higher COVID death odds in New York.
Among adults testing positive for COVID-19 in a large New York health system in spring 2020, those with a prior schizophrenia-spectrum diagnosis had 2.67 times the odds of dying (or going to hospice) within 45 days versus patients with no psychiatric disorder, after adjusting for other risk factors. Only age was a stronger risk. Mood and anxiety disorders were not linked.
It marks people with schizophrenia as one of the highest-risk groups, second only to older age in this study, who need protection and early care in outbreaks. Why they fare worse, whether biology, other illnesses or barriers to care, is still unclear. Only 75 patients had schizophrenia and all were from one New York system early in 2020, so the estimate is imprecise and cannot show why the link exists.
A records study of 7348 adults who tested positive for COVID-19 in a New York academic health system between March and May 2020, each followed for 45 days.
From the study: “a premorbid diagnosis of a schizophrenia spectrum disorder was significantly associated with mortality (odds ratio [OR], 2.67; 95% CI, 1.48-4.80).”
2.7× odds of dying
Nemani K et al. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA psychiatry. 2021.
From the study: “Diagnoses of mood disorders (OR, 1.14; 95% CI, 0.87-1.49) and anxiety disorders (OR, 0.96; 95% CI, 0.65-1.41) were not associated with mortality after adjustment.”
2.7× odds of dying
Nemani K et al. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA psychiatry. 2021.
From the study: “In comparison with other risk factors, a diagnosis of schizophrenia ranked behind only age in strength of an association with mortality.”
2.7× odds of dying
Nemani K et al. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA psychiatry. 2021.
50.6% more ER visitsWeekly ED visits for suspected suicide attempts, girls 12-17, early 2021 vs 2019
Teen girls' emergency visits for suspected suicide attempts rose sharply in 2021.
In US emergency departments, girls aged 12-17 made 50.6% more weekly visits for suspected suicide attempts in February and March 2021 than in the same weeks of 2019. Among boys the same age, the rise was only 3.7%. The increase in girls began in May 2020 and stayed high through the end of the study.
Teenage girls showed the sharpest sign of distress in the pandemic data. Visits for suspected attempts are a warning sign even when deaths do not rise, and show where school, family and clinic support was most needed. These are visit counts from about 71% of US emergency departments, not deaths, and families spending more time at home may have spotted and brought in struggling teens more often.
A CDC analysis of national emergency department surveillance data on visits by 12- to 25-year-olds from January 2019 to May 2021.
From the study: “during February 21-March 20, 2021, mean weekly ED visit counts for suspected suicide attempts were 50.6% higher among girls aged 12-17 years compared with the same period in 2019”
50.6% more ER visits
Yard E et al. Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021. MMWR. Morbidity and mortality weekly report. 2021.
From the study: “among boys aged 12–17 years, suspected suicide attempt ED visits increased 3.7%.”
50.6% more ER visits
Yard E et al. Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021. MMWR. Morbidity and mortality weekly report. 2021.
From the study: “this does not mean that suicide deaths have increased”
50.6% more ER visits
Yard E et al. Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021. MMWR. Morbidity and mortality weekly report. 2021.
Suicide rate fell 3%Change in the US age-adjusted suicide rate from 2019 to 2020
US suicide rate fell in 2020 instead of rising as feared.
Many experts feared isolation and economic decline would drive US suicides up in 2020. Instead, the national suicide rate fell 3% from 2019 to 2020, including 8% among women and 2% among men, with significant drops in seven states. Still, 12.2 million US adults reported serious thoughts of suicide in 2020.
The feared surge in suicide deaths did not appear in the first pandemic year. But the rate is still 30% higher than in 2000, and warning signs such as emergency visits by teen girls rose, so this is no all-clear. This national death-data report covers only 2019 and 2020, so it cannot explain the drop or show what happened in later pandemic years.
A CDC analysis of national US mortality data comparing suicide counts and age-adjusted rates in 2019 and 2020 by sex, age, method, county type and state.
From the study: “From 2019 to 2020, the suicide rate declined by 3% overall, including 8% among females and 2% among males.”
Suicide rate fell 3%
Ehlman DC et al. Changes in Suicide Rates - United States, 2019 and 2020. MMWR. Morbidity and mortality weekly report. 2022.
From the study: “Despite two consecutive years of declines, the overall suicide rate remains 30% higher compared with that in 2000”
Suicide rate fell 3%
Ehlman DC et al. Changes in Suicide Rates - United States, 2019 and 2020. MMWR. Morbidity and mortality weekly report. 2022.
From the study: “During 2020, a total of 12.2 million U.S. adults reported serious thoughts of suicide and 1.2 million attempted suicide”
Suicide rate fell 3%
Ehlman DC et al. Changes in Suicide Rates - United States, 2019 and 2020. MMWR. Morbidity and mortality weekly report. 2022.
1.5× as many visitsRate ratio for under-19s' eating-disorder healthcare visits, pandemic vs before
Youth care for eating disorders rose sharply during the pandemic.
Across 52 studies in 15 countries, children and teens under 19 used emergency, inpatient and outpatient care for eating disorders at 1.54 times the pre-pandemic rate. Emergency department use rose most (rate ratio 1.70). The rise was larger in girls than boys and in teens than younger children, and anorexia nervosa (severe food restriction) increased.
It confirms what many families and pediatricians saw: the pandemic years brought far more young people, mostly teen girls, into care for eating disorders. Whether the rise has lasted beyond the pandemic is still being tracked. Healthcare visits are not the same as new cases, since visit rates also reflect changes in access and referral across very different health systems.
A meta-analysis pooling 52 studies of more than 148,000 eating-disorder visits by under-19s across 15 countries, comparing the pandemic with earlier years.
From the study: “There was strong evidence of an increase in healthcare use for eating disorders during the pandemic (rate ratio [RR] = 1.54, 95% CI = 1.38-1.71).”
1.5× as many visits
Madigan S et al. A Systematic Review and Meta-Analysis: Child and Adolescent Healthcare Utilization for Eating Disorders During the COVID-19 Pandemic. Journal of the American Academy of Child and Adolescent Psychiatry. 2025.
From the study: “Moderator analysis revealed larger rate increases among girls (RR = 1.48, 95% CI = 1.28-1.71) compared to boys (RR = 1.24, 95% CI = 1.06-1.45)”
1.5× as many visits
Madigan S et al. A Systematic Review and Meta-Analysis: Child and Adolescent Healthcare Utilization for Eating Disorders During the COVID-19 Pandemic. Journal of the American Academy of Child and Adolescent Psychiatry. 2025.
From the study: “Moderator analysis demonstrated strong evidence of increased use of emergency department (RR = 1.70, 95% CI = 1.48-1.97)”
1.5× as many visits
Madigan S et al. A Systematic Review and Meta-Analysis: Child and Adolescent Healthcare Utilization for Eating Disorders During the COVID-19 Pandemic. Journal of the American Academy of Child and Adolescent Psychiatry. 2025.
Gains lasted 12 monthsOnline group exercise and psychological support vs usual care in long COVID
Online group rehab eased long COVID symptoms for a full year.
In 585 adults in England and Wales with long COVID (symptoms lasting months) after a hospital stay, an eight-week online programme of live group exercise and psychological support improved quality of life more than a single advice session. The benefit, driven mainly by less depression, fatigue and pain, was still present at 12 months, though the difference was modest.
Long COVID has few proven treatments. This randomized trial shows a home-based, online programme can modestly improve mood, fatigue and daily life for at least a year, and it could reach many people at once. All participants had been hospitalized for COVID and most were white, and only 47% completed the full programme, so results may differ for people with milder illness.
A randomized controlled trial in England and Wales that enrolled 585 adults with long COVID after hospital discharge between January 2021 and July 2022.
From the study: “Effects were sustained at 12 months (0.03 (0.01 to 0.06), P=0.02).”
Gains lasted 12 months
McGregor G et al. Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial. BMJ (Clinical research ed.). 2024.
From the study: “driven predominantly by greater improvements in the PROMIS subscores for depression (1.39 (0.06 to 2.71), P=0.04), fatigue (2.50 (1.19 to 3.81), P<0.001)”
Gains lasted 12 months
McGregor G et al. Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial. BMJ (Clinical research ed.). 2024.
1 in 4 health workersShare of health workers screening positive for probable PTSD during the pandemic
About 1 in 4 health workers had probable PTSD during the pandemic.
Pooling 129 studies of health workers during the pandemic and 21 from just before it, 24.8% screened positive for probable PTSD (post-traumatic stress disorder, lasting distress after trauma) during the pandemic, versus 15.5% beforehand. Rates were highest among nurses and where COVID deaths were high, peaked in 2020, and fell back to pre-pandemic levels by 2022.
Nurses and doctors carried a heavy psychological load. The return to earlier levels is encouraging, but even the pre-pandemic rate, about 1 in 6, is high, and a future health emergency could push it up again. Most studies used screening questionnaires on self-selected volunteers rather than clinical interviews, so 'probable PTSD' may overstate diagnosable illness.
A systematic review and meta-analysis of 21 pre-pandemic and 129 pandemic-era studies of clinical health workers worldwide, published between 2017 and 2023.
From the study: “The pooled prevalence estimate of probable PTSD prior to the pandemic was 15.5% (95% CI: 12.3-19.3%) and this significantly increased during the pandemic to 24.8% (95% CI: 22.0-27.8%)”
1 in 4 health workers
Frodsham C et al. Prevalence of post-traumatic stress disorder in healthcare workers before and during COVID-19: a systematic review and meta-analysis. Frontiers in public health. 2026.
From the study: “peaking early in the pandemic in 2020 before returning to pre-pandemic levels in 2022”
1 in 4 health workers
Frodsham C et al. Prevalence of post-traumatic stress disorder in healthcare workers before and during COVID-19: a systematic review and meta-analysis. Frontiers in public health. 2026.
From the study: “During the pandemic, prevalence estimates were significantly higher among nurses and those in countries with high COVID-19 mortality rates”
1 in 4 health workers
Frodsham C et al. Prevalence of post-traumatic stress disorder in healthcare workers before and during COVID-19: a systematic review and meta-analysis. Frontiers in public health. 2026.
Study-specific findings. Different populations, treatments and follow-up periods can produce different results.
Depression outcomes differed between the treated patient groups
The study reported less depression-score improvement and lower remission in Long COVID-associated depression than primary major depressive disorder after intermittent theta burst stimulation.
One symptom-improvement finding specifies medication-free patients and left dorsolateral prefrontal cortex stimulation. Results include matched comparisons and separately adjusted analyses; residual unmeasured confounding remains possible.
Study details & original results
Noda, Yoshihiro et al.. Comparative Treatment Response to Intermittent Theta Burst Stimulation in Long COVID-Associated Depression Versus Major Depressive Disorder: A Propensity Score-Matched Retrospective Cohort Study.. Biomedicines. 2026.
MADRS improvement after left dorsolateral prefrontal cortex iTBS in medication-free patients with Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
38.4% vs. 61.5%
HAM-D17 remission after iTBS in Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
27.3% vs. 61.4%
HAM-D17 improvement after iTBS in Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
36.7% vs. 58.4%
Adjusted HAM-D17 improvement difference for Long COVID-associated depression versus primary MDD using IPTW and doubly robust models; residual unmeasured confounding cannot be excluded.
-21.8 percentage points; p < 0.001
Adjusted MADRS improvement difference for Long COVID-associated depression versus primary MDD using IPTW and doubly robust models; residual unmeasured confounding cannot be excluded.
Brain fog was reported in the reviewed Long COVID populations
30%
The review reports brain fog in 30% and cognitive impairment in 25% of the Long COVID populations it examined.
These are separate measures from a systematic review, not risks for everyone after infection. Their overlap is not established in this summary, so the percentages cannot be added.
Study details & original results
Faseeh, Ahmar et al.. Prevalence and long-term outcomes of brain fog and cognitive impairment in individuals with long COVID: A systematic review.. Medicine. 2026.
Brain fog prevalence in long COVID populations
30% 95% CI: 28-32
Cognitive impairment prevalence in long COVID populations
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
Browse all 7 recorded findingsSearch the original results, comparisons and study details.
2 of 2 source groupsFindings stay together with their study.
SOURCE 045 findings
Noda, Yoshihiro et al.. Comparative Treatment Response to Intermittent Theta Burst Stimulation in Long COVID-Associated Depression Versus Major Depressive Disorder: A Propensity Score-Matched Retrospective Cohort Study.. Biomedicines. 2026.
MADRS improvement after left dorsolateral prefrontal cortex iTBS in medication-free patients with Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
HAM-D17 improvement after iTBS in Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
Adjusted MADRS improvement difference for Long COVID-associated depression versus primary MDD using IPTW and doubly robust models; residual unmeasured confounding cannot be excluded.
Adjusted HAM-D17 improvement difference for Long COVID-associated depression versus primary MDD using IPTW and doubly robust models; residual unmeasured confounding cannot be excluded.
HAM-D17 remission after iTBS in Long COVID-associated depression versus propensity-matched primary MDD; retrospective observational association with residual unmeasured confounding possible.
Faseeh, Ahmar et al.. Prevalence and long-term outcomes of brain fog and cognitive impairment in individuals with long COVID: A systematic review.. Medicine. 2026.
Browse the 13 original sourcesThe complete bibliography behind this monitor.
[1]
Ryu, Soomin et al.. Prospective associations between Long COVID and mental health: evidence from a population-based study with a nearly three-year follow-up.. BMC public health. 2026.
Faseeh, Ahmar et al.. Prevalence and long-term outcomes of brain fog and cognitive impairment in individuals with long COVID: A systematic review.. Medicine. 2026.
Cho, Jaehyeong et al.. Post-Acute Sequelae of COVID-19 Across 15 Major Health Domains and 67 Diseases in Individuals With Depressive Disorder: A Korean Nationwide Cohort Study.. Journal of Korean medical science. 2026.
Noda, Yoshihiro et al.. Comparative Treatment Response to Intermittent Theta Burst Stimulation in Long COVID-Associated Depression Versus Major Depressive Disorder: A Propensity Score-Matched Retrospective Cohort Study.. Biomedicines. 2026.
Reinke, Max et al.. Frequency and correlates of somatic symptom disorder in patients with post COVID-19 condition: Cross-sectional results from the SOMA.COV study.. Journal of psychosomatic research. 2026. [Source notice: Published online 2026-10-07 (PubMed 42868975); print issue dated January 2027.]
Taquet M et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The lancet. Psychiatry. 2022.
Yard E et al. Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021. MMWR. Morbidity and mortality weekly report. 2021.
Madigan S et al. A Systematic Review and Meta-Analysis: Child and Adolescent Healthcare Utilization for Eating Disorders During the COVID-19 Pandemic. Journal of the American Academy of Child and Adolescent Psychiatry. 2025.
McGregor G et al. Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial. BMJ (Clinical research ed.). 2024.
Frodsham C et al. Prevalence of post-traumatic stress disorder in healthcare workers before and during COVID-19: a systematic review and meta-analysis. Frontiers in public health. 2026.
Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results. Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed.
Download the findings and bibliography displayed in this page snapshot. Values and confidence intervals remain as reported text; this is not a pooled estimate or a systematic review. Product-label observations and editorial takeaways are excluded.
These findings may omit evidence or contain errors and have not been reviewed by a clinician. A citation or download does not establish source verification. Read the original studies for their methods and limitations.
The October 2026 COVID citation audit found errors in this collection. These downloads may still contain affected findings and bibliography entries. Read the correction record before using them.
“Added” dates record entry into the monitor, not publication or clinical review. A null original acquisition or derivation means its historical record is unknown; a current record or verification has its own observation time. The SHA-256 snapshot identifier binds the downloadable public fields. CSV includes finding rows and bibliography-only source rows; JSON includes both lists. Spreadsheet-sensitive CSV cells begin with an apostrophe for safety; JSON preserves the original text.
For attribution, cite ModernDoc and the page URL, data update date and snapshot identifier in the download. Original studies retain their own rights; this download does not grant a licence to their full text.